GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system

Authors

Paul W. Hruz, Washington University School of Medicine in St. Louis
Qingyun Yan, Washington University School of Medicine in St. Louis
Luong Tsai, Gilead Sciences
Joseph Koster, Washington University School of Medicine in St. LouisFollow
Lianhong Xu, Gilead Sciences
Tomas Cihlar, Gilead Sciences
Christian Callebaut, Gilead Sciences

Journal

Antimicrobial Agents and Chemotherapy

Publication Date

2011

Volume

55

Issue

4

Inclusive Pages

1377

Document Type

Open Access Publication

DOI

10.1128/AAC.01184-10

Rights and Permissions

Hruz, P. W., Yan, Q., Tsai, L., Koster, J., Xu, L., Cihlar, T., & Callebaut, C. (2011). GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system. Antimicrobial Agents and Chemotherapy, 55(4), 1377-1382. DOI: 10.1128/AAC.01184-10

Recommended Citation

Hruz, Paul W.; Yan, Qingyun; Tsai, Luong; Koster, Joseph; Xu, Lianhong; Cihlar, Tomas; and Callebaut, Christian, "GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system." Antimicrobial Agents and Chemotherapy. 55, 4. 1377. (2011).
https://digitalcommons.wustl.edu/open_access_pubs/2338